<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01354821</url>
  </required_header>
  <id_info>
    <org_study_id>P090209</org_study_id>
    <nct_id>NCT01354821</nct_id>
  </id_info>
  <brief_title>Medical &amp; Economical Evaluation of Fenestrated &amp; Branched Stent-grafts to Treat Complex Thoracal Abdominal Aneurysms</brief_title>
  <acronym>Windows2</acronym>
  <official_title>Medical &amp; Economical Evaluation of Endovascular Therapy of Complex Thoracal Abdominal Aneurysms (Type 1-3 Thoracal Abdominal Aneurysms) by Fenestrated &amp; Branched Stent-grafts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to prospectively compare the perioperative mortality severe
      morbidity and the costs of endovascular versus conventional surgical repair of type 1, 2 and
      3 thoracal abdominal aortic aneurysms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to prospectively compare the perioperative mortality severe
      morbidity and the costs of endovascular versus conventional surgical repair of type 1, 2 and
      3 thoracal abdominal aortic aneurysms.

      The primary goal of the study is to demonstrate a significant drop in 30-day mortality and
      life threatening morbidity in the endovascular arm of the study. Our hypothesis, derived from
      the literature, that the average 30-days mortality is 3% after endovascular repair and 10%
      after open surgery justifies the design of a prospective study between endovascular therapy
      (50 patients (amendment n.5 - 9/07/2013) treated in 5 University hospitals with significant
      experience of the technique) and open repair (220 similar patients analyzed from the national
      database of the MOH).

      In-hospital morbidity are similarly expected to be lower in the endovascular group. The
      investigators also wish to demonstrate that endovascular repair does not represent a
      significant overcost, as compared to open repair. The cost of the implantable medical device
      (IMD), of follow-up screening, and of eventual repeated interventions should be compensated
      by a reduced stay in intensive care unit ICU, and by a reduced in-hospital length of stay.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>30-day postoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>complications</measure>
    <time_frame>30-day postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Intensive Care Unit (ICU) stay</measure>
    <time_frame>30-day postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital stay</measure>
    <time_frame>30-day postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall cost</measure>
    <time_frame>30-day postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reinterventions</measure>
    <time_frame>2-year follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global survival</measure>
    <time_frame>2-year follow up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>Endovascular therapy branched</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endovascular therapy branched or fenestrated stent-graft</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Open surgical repair</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Open surgical repair or aortic replacement with revascularization of visceral arteries</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endovascular aortic repair</intervention_name>
    <description>Insertion via bilateral femoral access, stent-graft deployment under fluoroscopic guidance, complementary stenting of visceral arteries, control angiogram</description>
    <arm_group_label>Endovascular therapy branched</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open surgical repair</intervention_name>
    <description>Conventional therapy in France with the national database of the M.O.H.</description>
    <arm_group_label>Open surgical repair</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        The following anatomical inclusion criteria must be met:

          -  Absence of significant angulations (&lt; 60°) of aorta or of iliac arteries

          -  Absence of tight stenosis (&gt;70%) of more than one target artery (renal or visceral
             artery to be perfused from the side holes of the stent-graft)

          -  Diameter of target arteries over 5 mm

          -  Iliac and femoral arteries allowing insertion of the delivery system (&gt; 7 mm) or
             suitable for insertion of an access conduit

        Exclusion Criteria:

          -  Limited expected life expectancy

          -  Emergency cases

          -  Refuse to participate to the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Pierre Becquemin, PU-PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Henri Mondor Hospital</name>
      <address>
        <city>Creteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.vasculaire.mondor.aphp.fr</url>
    <description>PMID: 20093051</description>
  </link>
  <reference>
    <citation>Amiot S, Haulon S, Becquemin JP, Magnan PE, Lermusiaux P, Goueffic Y, Jean-Baptiste E, Cochennec F, Favre JP; Association Universitaire de Recherche en Chirurgie Vasculaire. Fenestrated endovascular grafting: the French multicentre experience. Eur J Vasc Endovasc Surg. 2010 May;39(5):537-44. doi: 10.1016/j.ejvs.2009.12.008. Epub 2010 Jan 25.</citation>
    <PMID>20093051</PMID>
  </reference>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2011</study_first_submitted>
  <study_first_submitted_qc>May 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 17, 2011</study_first_posted>
  <last_update_submitted>October 29, 2014</last_update_submitted>
  <last_update_submitted_qc>October 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 30, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aorta</keyword>
  <keyword>Aneurysm</keyword>
  <keyword>endovascular</keyword>
  <keyword>stent-graft</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

